OSR Holdings, Inc
@osrholdings.bsky.social
An Open and Socially Responsible Healthcare Group
Pinned
Website: osr-holdings.com
Contact IR: [email protected]
Ticker: $OSRH (NASDAQ)
Thank you for following our journey!
Contact IR: [email protected]
Ticker: $OSRH (NASDAQ)
Thank you for following our journey!
May 22, 2025 at 10:40 AM
Very much looking forward to our poster presentation at TIMO XIX 2025 tomorrow!
Vaximm, and OSR company, will be featuring a poster on it's VXM01 novel anti-VEGFR-2 oral vaccine, following the recent conclusion of Phase 2a clinical trials in patients with recurrant #glioblastoma.
Vaximm, and OSR company, will be featuring a poster on it's VXM01 novel anti-VEGFR-2 oral vaccine, following the recent conclusion of Phase 2a clinical trials in patients with recurrant #glioblastoma.
May 21, 2025 at 6:25 AM
Very much looking forward to our poster presentation at TIMO XIX 2025 tomorrow!
Vaximm, and OSR company, will be featuring a poster on it's VXM01 novel anti-VEGFR-2 oral vaccine, following the recent conclusion of Phase 2a clinical trials in patients with recurrant #glioblastoma.
Vaximm, and OSR company, will be featuring a poster on it's VXM01 novel anti-VEGFR-2 oral vaccine, following the recent conclusion of Phase 2a clinical trials in patients with recurrant #glioblastoma.
A reminder and solid write-up on recent VXM01 clinical phase 2a trial results for Vaximm, an OSR Company.
www.onclive.com/view/vxm01-p...
www.onclive.com/view/vxm01-p...
VXM01 Plus Avelumab Is Safe and Shows Preliminary Clinical Activity in Recurrent Glioblastoma
The combination of VXM01 and avelumab was well tolerated and has the potential to generate clinically meaningful responses in recurrent glioblastoma.
www.onclive.com
May 12, 2025 at 5:55 AM
A reminder and solid write-up on recent VXM01 clinical phase 2a trial results for Vaximm, an OSR Company.
www.onclive.com/view/vxm01-p...
www.onclive.com/view/vxm01-p...
We are happy to announce that Darnatein, an OSR company, will be presenting scientific data at the 14th International BMP Conference in Philadelphia.
#designaugmented #bone #cartilage #regeneration
www.prnewswire.com/news-release...
#designaugmented #bone #cartilage #regeneration
www.prnewswire.com/news-release...
Darnatein to Present at 14th International BMP Conference Highlighting Advances in Regenerative Biologics
/PRNewswire/ -- Darnatein, a subsidiary of OSR Holdings, Inc. (NASDAQ: OSRH), a biotechnology company advancing design-augmented biologics, announced today...
www.prnewswire.com
May 2, 2025 at 11:53 AM
We are happy to announce that Darnatein, an OSR company, will be presenting scientific data at the 14th International BMP Conference in Philadelphia.
#designaugmented #bone #cartilage #regeneration
www.prnewswire.com/news-release...
#designaugmented #bone #cartilage #regeneration
www.prnewswire.com/news-release...
Website: osr-holdings.com
Contact IR: [email protected]
Ticker: $OSRH (NASDAQ)
Thank you for following our journey!
Contact IR: [email protected]
Ticker: $OSRH (NASDAQ)
Thank you for following our journey!
April 21, 2025 at 7:50 AM
Website: osr-holdings.com
Contact IR: [email protected]
Ticker: $OSRH (NASDAQ)
Thank you for following our journey!
Contact IR: [email protected]
Ticker: $OSRH (NASDAQ)
Thank you for following our journey!
OSR’s finest!! Constance Höfer and Seb Wieckowski represented us proudly at D.B.T. 2025 in Heidelberg last week.
2 days of successful meetings. More details to follow!
2 days of successful meetings. More details to follow!
April 13, 2025 at 12:56 AM
OSR’s finest!! Constance Höfer and Seb Wieckowski represented us proudly at D.B.T. 2025 in Heidelberg last week.
2 days of successful meetings. More details to follow!
2 days of successful meetings. More details to follow!
OSR Holdings is excited to be attending D.B.T. 2025 in Heidelberg this week.
We look forward to connecting to exchange ideas on R&D, talk with CROs on advancing the pipeline, and build new partnerships!
www.german-biotech.day
We look forward to connecting to exchange ideas on R&D, talk with CROs on advancing the pipeline, and build new partnerships!
www.german-biotech.day
German Biotechnology Days 2025
The German Biotechnology Days will take place in Heidelberg on 9 and 10 April 2025.
www.german-biotech.day
April 7, 2025 at 6:54 AM
OSR Holdings is excited to be attending D.B.T. 2025 in Heidelberg this week.
We look forward to connecting to exchange ideas on R&D, talk with CROs on advancing the pipeline, and build new partnerships!
www.german-biotech.day
We look forward to connecting to exchange ideas on R&D, talk with CROs on advancing the pipeline, and build new partnerships!
www.german-biotech.day
